StockData
Rallybio Corp logo

Rallybio Corp (RLYB) stock

RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/30
$15.29−0.14 (-0.88%)

Close on Nov 17, 2026Market cap $82.32MP/E 3.4Yield –

Rallybio operating margin

Operating margin is operating income as a percentage of revenue.

Rallybio's operating margin for the twelve months ending Sep 30, 2026 was -5580.9%. For fiscal 2025 it was -3853.6%, against -9511.9% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-3853.6%+5658.3
FY2024Dec 31, 2024-9511.9%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2026Mar 31, 2026-4119.3%+442.0
Q4 FY2025Dec 31, 2025-2888.3%+27659.1
Q3 FY2025Sep 30, 2025-3266.5%+768.9
Q2 FY2025Jun 30, 2025-4743.9%+953.5
Q1 FY2025Mar 31, 2025-4561.3%–
Q4 FY2024Dec 31, 2024-30547.4%–
Q3 FY2024Sep 30, 2024-4035.5%–
Q2 FY2024Jun 30, 2024-5697.3%–

More Rallybio figures

See a number that looks wrong?